Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1996;16:1481-1487

This Article
Right arrow Full Text
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kreuzer, J.
Right arrow Articles by Kubler, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kreuzer, J.
Right arrow Articles by Kubler, W.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1996;16:1481-1487.)
© 1996 American Heart Association, Inc.


Articles

LDL Stimulates Chemotaxis of Human Monocytes Through a Cyclooxygenase-Dependent Pathway

Jorg Kreuzer; Stefanie Denger; Lothar Jahn; Jorg Bader; Kai Ritter; Eberhard von Hodenberg; Wolfgang Kubler

the Innere Medizin III, Universitat Heidelberg, Heidelberg, Germany.

Correspondence to Jorg Kreuzer, MD, Universitat Heidelberg, Innere Medizin III, Bergheimer Str 58, 69115 Heidelberg, Germany.

Monocyte migration into the vessel wall is an early step in atherogenesis. Even though a number of chemotactic factors have been identified, the regulation of the chemotactic response is not clearly understood. As the release of arachidonic acid has been implicated in monocyte chemotaxis, we studied the influence of LDL, which can supply this fatty acid to cells, on the chemotactic mobility of monocytes. Migration of human monocytic U937 cells was abolished by a 30-hour incubation in medium containing lipoprotein-depleted 10% fetal calf serum. Thereafter, human VLDL, LDL, acetyl LDL, methyl LDL, HDL, free cholesterol, linoleic acid, oleic acid, or arachidonic acid was added. At the end of varying incubation periods (0.5 to 8 hours), chemotaxis, viability, and cellular cholesterol content were measured. In the same experimental setting we also studied the effects of the pharmacological agents chloroquine, indomethacin, and acetylsalicylic acid on LDL-mediated chemotaxis. Chemotaxis was restored by LDL in a dose- and time-dependent manner starting at concentrations as low as 5 µg/mL and at incubations as brief as 30 minutes. The other lipoproteins tested (VLDL, HDL, acetyl LDL, and methyl LDL) as well as free cholesterol had no comparable effect on chemotaxis. Viability and total cholesterol content did not differ among the groups. Simultaneous incubation of cells with chloroquine, indomethacin, and acetylsalicylic acid reduced restitution of chemotaxis by LDL by 71%, 82%, and 68%, respectively. In contrast, the agents had only slight inhibitory effects on the chemotactic mobility of serum-fed control cells. Incubation with linoleic acid showed a 60% restoration of chemotaxis, whereas arachidonic acid stimulated chemotaxis by 140% compared with the positive control. Preincubation of LDL with the monoclonal antibody MB47 directed against LDL resulted in a significantly reduced migratory response. The data suggest a novel cyclooxygenase-dependent regulatory mechanism of chemotaxis by LDL.


Key Words: chemotaxis • U937 cells • LDL • arachidonic acid • cyclooxygenase




This article has been cited by other articles:


Home page
Clin. Chem.Home page
S.-p. Zhao, P. Deng, H.-g. Huang, Z.-m. Xu, H.-y. Dai, S.-c. Hong, J. Yang, and H.-n. Zhou
Expression of COX-2 mRNA in Peripheral Blood Monocytes from Patients with Acute Myocardial Infarction and Its Significance
Clin. Chem., November 1, 2005; 51(11): 2170 - 2173.
[Full Text] [PDF]


Home page
Eur Heart JHome page
O. Beloqui, J. A. Paramo, J. Orbe, A. Benito, I. Colina, A. Monasterio, and J. Diez
Monocyte cyclooxygenase-2 overactivity: a new marker of subclinical atherosclerosis in asymptomatic subjects with cardiovascular risk factors?
Eur. Heart J., January 2, 2005; 26(2): 153 - 158.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Cipollone, B. Rocca, and C. Patrono
Cyclooxygenase-2 Expression and Inhibition in Atherothrombosis
Arterioscler Thromb Vasc Biol, February 1, 2004; 24(2): 246 - 255.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
M. G. Netea, B. J. Kullberg, P. N. M. Demacker, L. E. H. Jacobs, T. J. G. Verver-Jansen, A. Hijmans, L. H. J. van Tits, J. G. J. Hoenderop, P. H. G. M. Willems, J. W. M. Van der Meer, et al.
Native LDL potentiate TNF{alpha} and IL-8 production by human mononuclear cells
J. Lipid Res., July 1, 2002; 43(7): 1065 - 1071.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. A. Carnevale and M. K. Cathcart
Calcium-Independent Phospholipase A2 Is Required for Human Monocyte Chemotaxis to Monocyte Chemoattractant Protein 1
J. Immunol., September 15, 2001; 167(6): 3414 - 3421.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
R. A. Stockton and B. S. Jacobson
Modulation of Cell-Substrate Adhesion by Arachidonic Acid: Lipoxygenase Regulates Cell Spreading and ERK1/2-inducible Cyclooxygenase Regulates Cell Migration in NIH-3T3 Fibroblasts
Mol. Biol. Cell, July 1, 2001; 12(7): 1937 - 1956.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. S. R. Baker, R. J. C. Hall, T. J. Evans, A. Pomerance, J. Maclouf, C. Creminon, M. H. Yacoub, and J. M. Polak
Cyclooxygenase-2 Is Widely Expressed in Atherosclerotic Lesions Affecting Native and Transplanted Human Coronary Arteries and Colocalizes With Inducible Nitric Oxide Synthase and Nitrotyrosine Particularly in Macrophages
Arterioscler Thromb Vasc Biol, March 1, 1999; 19(3): 646 - 655.
[Abstract] [Full Text] [PDF]